Market Overview - The U.S. equity market experienced a significant recovery in Q2 2025, rising 23% from its low to end the quarter at a record high [1] - U.S. large-cap stocks gained 11.1% during the quarter, with growth stocks outperforming value stocks [1] Fund Performance - The Meridian Contrarian Fund achieved a return of 16.42% (net) in Q2 2025, surpassing the Russell 2500 Index's return of 8.59% and the Russell 2500 Value Index's return of 7.29% [1] Company Highlight: Cameco Corporation - Cameco Corporation (NYSE:CCJ) is identified as a leading uranium producer, with a one-month return of 10.69% and a 52-week gain of 78.53% [2] - As of September 25, 2025, Cameco's stock closed at $85.66 per share, with a market capitalization of $37.418 billion [2] Investment Thesis on Cameco Corporation - Cameco is recognized as a best-in-class operator in uranium mining, with world-leading reserves and a low-cost production profile [3] - The company has gained attractiveness as global uranium production has fallen below demand, particularly after the 2011 Fukushima disaster [3] - The investment thesis is based on the expectation of recovering uranium prices and renewed interest in nuclear power, which has gained broader investor acceptance [3] - The stock saw a strong rebound in Q2 2025 due to increasing momentum around nuclear power from various stakeholders [3] - The fund engaged in both buying and selling shares of Cameco during the quarter, managing risk through net selling into strength [3]